Incidence of PTSD in the French population a month after the COVID-19 pandemic-related lockdown: evidence from a national longitudinal survey.


Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
05 08 2022
Historique:
received: 09 05 2021
accepted: 25 07 2022
entrez: 5 8 2022
pubmed: 6 8 2022
medline: 10 8 2022
Statut: epublish

Résumé

In view of experts' warnings about the potential negative mental health consequences of the sudden nationwide lockdowns implemented in many countries to limit the spread of the COVID-19 pandemic, we sought to study the incidence of posttraumatic stress disorder (PTSD) after traumatic events related to this unprecedented lockdown in the French general population. This longitudinal study among adults (aged =18) consisted of two surveys: the first during the last days of the lockdown and the second a month later. We estimated PTSD incidence with the PCL-5 and ran multiple Poisson regression models to identify factors associated with PTSD. Among the 1736 participants, 30.1% reported at least one traumatic event. PTSD incidence was 17.5% (95% confidence interval CI = 15.7-19.3). It was higher in participants who reported multiple traumatic events, who had high COVID-19-related media use, who had general anxiety disorder (GAD-7) during the lockdown, and who had GAD, depression (PHQ-9), or sleep problems 1 month later. In addition, 43.1% of people with PTSD reported suicidal thoughts. These results should help clinicians to target people who are at high risk of developing PTSD after a pandemic-related lockdown and could benefit from preventive measures. Collaboration between the media and mental health professionals could be envisioned to inform the population about care resources. Follow-up recommendations should also be disseminated to general practitioners to facilitate PTSD screening and ensure that they are aware of the appropriate management.

Sections du résumé

BACKGROUND
In view of experts' warnings about the potential negative mental health consequences of the sudden nationwide lockdowns implemented in many countries to limit the spread of the COVID-19 pandemic, we sought to study the incidence of posttraumatic stress disorder (PTSD) after traumatic events related to this unprecedented lockdown in the French general population.
METHODS
This longitudinal study among adults (aged =18) consisted of two surveys: the first during the last days of the lockdown and the second a month later. We estimated PTSD incidence with the PCL-5 and ran multiple Poisson regression models to identify factors associated with PTSD.
RESULTS
Among the 1736 participants, 30.1% reported at least one traumatic event. PTSD incidence was 17.5% (95% confidence interval CI = 15.7-19.3). It was higher in participants who reported multiple traumatic events, who had high COVID-19-related media use, who had general anxiety disorder (GAD-7) during the lockdown, and who had GAD, depression (PHQ-9), or sleep problems 1 month later. In addition, 43.1% of people with PTSD reported suicidal thoughts.
CONCLUSIONS
These results should help clinicians to target people who are at high risk of developing PTSD after a pandemic-related lockdown and could benefit from preventive measures. Collaboration between the media and mental health professionals could be envisioned to inform the population about care resources. Follow-up recommendations should also be disseminated to general practitioners to facilitate PTSD screening and ensure that they are aware of the appropriate management.

Identifiants

pubmed: 35932014
doi: 10.1186/s12889-022-13880-9
pii: 10.1186/s12889-022-13880-9
pmc: PMC9356417
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1500

Investigateurs

Patrick Peretti-Watel (P)
Valérie Seror (V)
Sébastien Cortaredona (S)
Odile Launay (O)
Jocelyn Raude (J)
Pierre Verger (P)
Caroline Alleaume (C)
Lisa Fressard (L)
Guillaume Vaiva (G)
François Beck (F)
Stéphane Legleye (S)
Damien Léger (D)
Olivier L'Haridon (O)
Jeremy K Ward (JK)

Informations de copyright

© 2022. The Author(s).

Références

Arch Gen Psychiatry. 1995 Dec;52(12):1048-60
pubmed: 7492257
J Affect Disord. 2020 Dec 1;277:368-374
pubmed: 32861837
J Anxiety Disord. 2009 Jan;23(1):77-86
pubmed: 18511232
PLoS One. 2022 Feb 16;17(2):e0263666
pubmed: 35171915
Gen Hosp Psychiatry. 2009 Jul-Aug;31(4):318-26
pubmed: 19555791
Psychiatry. 2002 Winter;65(4):289-300
pubmed: 12530330
Brain Behav Immun. 2020 Oct;89:594-600
pubmed: 32738287
Int J Nurs Stud. 2022 Feb;126:104136
pubmed: 34856503
J Affect Disord. 2020 Sep 1;274:1-7
pubmed: 32405111
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
Encephale. 2008 Dec;34(6):577-83
pubmed: 19081454
J Clin Psychol. 2011 Dec;67(12):1240-58
pubmed: 22065464
J Sleep Res. 2021 Feb;30(1):e13119
pubmed: 32596936
Psychiatry Res. 2020 Aug;290:113172
pubmed: 32512357
Behav Sci (Basel). 2017 Feb 13;7(1):
pubmed: 28208816
Br J Health Psychol. 2020 Nov;25(4):865-874
pubmed: 32415914
BMC Public Health. 2008 Oct 03;8:347
pubmed: 18831770
Med Care. 1990 Nov;28(11):1056-72
pubmed: 2250492
Int J Environ Res Public Health. 2020 Jun 10;17(11):
pubmed: 32532077
PLoS One. 2020 Apr 16;15(4):e0231924
pubmed: 32298385
Am J Psychiatry. 2009 Jan;166(1):34-41
pubmed: 19047323
PLoS One. 2016 Oct 10;11(10):e0161645
pubmed: 27723815
Gen Psychiatr. 2020 Sep 22;33(5):e100299
pubmed: 33083692
Brain Behav Immun. 2020 Jul;87:172-176
pubmed: 32405150
Transl Psychiatry. 2021 May 27;11(1):327
pubmed: 34045442
Clin Psychol Rev. 2009 Aug;29(6):471-82
pubmed: 19539412
Psychol Med. 2021 Jul;51(10):1773-1774
pubmed: 32326997

Auteurs

Caroline Alleaume (C)

Southeastern Health Regional Observatory (ORS Paca), Faculté des Sciences Médicales et Paramédicales, 27 Bd Jean Moulin 13385, CEDEX 5, Marseille, France. carolinealleaume@hotmail.fr.

Patrick Peretti-Watel (P)

Southeastern Health Regional Observatory (ORS Paca), Faculté des Sciences Médicales et Paramédicales, 27 Bd Jean Moulin 13385, CEDEX 5, Marseille, France.
Aix-Marseille University, IRD, AP-HM, SSA, VITROME, Marseille, France.

François Beck (F)

CESP, University Paris Sud, Faculté de médecine UVSQ, Inserm, University Paris-Saclay, Villejuif, France.

Damien Leger (D)

Université de Paris, EA 7330 VIFASOM (Vigilance Fatigue Sommeil et Santé Publique), Paris, France.
APHP- Hôtel-Dieu, Centre du sommeil et de la Vigilance, Paris, France.

Guillaume Vaiva (G)

U1172 INSERM Lille Neurosciences & Cognitions, Centre National de Ressources & Résilience pour les psychotraumatismes (Lille - Paris), Lille, France.

Pierre Verger (P)

Southeastern Health Regional Observatory (ORS Paca), Faculté des Sciences Médicales et Paramédicales, 27 Bd Jean Moulin 13385, CEDEX 5, Marseille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH